BeOne Medicines (ONC) Retained Earnings: 2015-2025
Historic Retained Earnings for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to -$8.4 billion.
- BeOne Medicines' Retained Earnings rose 0.81% to -$8.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 billion, marking a year-over-year increase of 0.81%. This contributed to the annual value of -$8.6 billion for FY2024, which is 8.10% down from last year.
- Latest data reveals that BeOne Medicines reported Retained Earnings of -$8.4 billion as of Q3 2025, which was up 1.47% from -$8.5 billion recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Retained Earnings registered a high of -$3.5 billion during Q1 2021, and its lowest value of -$8.6 billion during Q4 2024.
- In the last 3 years, BeOne Medicines' Retained Earnings had a median value of -$8.3 billion in 2024 and averaged -$8.2 billion.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 54.90% in 2022, then climbed by 0.81% in 2025.
- BeOne Medicines' Retained Earnings (Quarterly) stood at -$5.1 billion in 2021, then slumped by 39.47% to -$7.1 billion in 2022, then declined by 12.45% to -$8.0 billion in 2023, then dropped by 8.10% to -$8.6 billion in 2024, then rose by 0.81% to -$8.4 billion in 2025.
- Its last three reported values are -$8.4 billion in Q3 2025, -$8.5 billion for Q2 2025, and -$8.6 billion during Q1 2025.